News :: Ensysce Biosciences, Inc. (ENSC)

Recent NewsView All News

Sep 24, 2026 8:00am EDT

Ensysce Biosciences Phase 2 Protocol for CY200 - A Neuroplastigen for the Treatment of CRPS - Submitted to the UK MHRA

Sep 15, 2026 9:15am EDT

Ensysce Biosciences Advances CRPS Program at Painweek 2026, Contributes to FDA Hearing on Psychedelic Drug Regulation

Recent Events View All Events

Sep 28 – Sep 29, 2026

20th Annual Pain Therapeutics Summit

Sep 22, 2026

Life Sciences Product Launch Summit

Email Alerts

Sign up for email alerts for Press Releases & SEC Filings

In the NewsView All News

March 3, 2025

Ensysce Biosciences CEO Dr. Lynn Kirkpatrick and Creighton University's Dr. Neel Pathak Discuss the Opioid Crisis and Next Generation Opioids

January 29, 2024

In Conversation With: Dr Lynn Kirkpatrick, Ensysce Biosciences

December 20, 2023

Navigating the Future of Pain Management: Ensysce Biosciences’ Innovative Approach